CBIO
Crescent Biopharma
CBIO
CBIO
81 hedge funds and large institutions have $428M invested in Crescent Biopharma in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
36% less capital invested
Capital invested by funds: $668M → $428M (-$240M)
Holders
81
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.05M | |
| 2 | +$2.16M | |
| 3 | +$1.74M | |
| 4 |
Man Group
London,
United Kingdom
|
+$1.74M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.7M |
Top Sellers
| 1 | -$6.48M | |
| 2 | -$5.76M | |
| 3 | -$4.82M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.65M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.35M |